In the last trading session, 1.12 million shares of the Tempest Therapeutics Inc (NASDAQ:TPST) were traded, and its beta was -1.86. Most recently the company’s share price was $0.90, and it changed around $0.02 or 2.02% from the last close, which brings the market valuation of the company to $39.15M. TPST currently trades at a discount to its 52-week high of $6.00, offering almost -566.67% off that amount. The share price’s 52-week low was $0.70, which indicates that the current value has risen by an impressive 22.22% since then. We note from Tempest Therapeutics Inc’s average daily trading volume that its 10-day average is 0.9 million shares, with the 3-month average coming to 1.54 million.
Tempest Therapeutics Inc stock received a consensus recommendation rating of Overweight, based on a mean score of 1.00. If we narrow it down even further, the data shows that 0 out of 5 analysts rate the stock as a Sell; another 3 rate it as Overweight. Among the rest, 0 recommended TPST as a Hold, whereas 2 deemed it a Buy, and 0 rated it as Underweight. Tempest Therapeutics Inc is expected to report earnings per share of -0.25 for the current quarter.
Tempest Therapeutics Inc (NASDAQ:TPST) trade information
Instantly TPST has showed a green trend with a performance of 2.02% at the end of last trading. The performance over the last five days has remained in the red territory. The rise to weekly highs of 0.9600 on recent trading dayincreased the stock’s daily price by 6.25%. The company’s shares are currently up 7.50% year-to-date, but still down -3.44% over the last five days. On the other hand, Tempest Therapeutics Inc (NASDAQ:TPST) is -5.51% down in the 30-day period. We can see from the shorts that 2.64 million shares have been sold at a short interest cover period of 0.39 day(s).
Tempest Therapeutics Inc (TPST) estimates and forecasts
Looking at the company’s year-over-year earnings, the past five years showed a positive earnings growth rate of 62.66%. Tempest Therapeutics Inc earnings are expected to increase by 29.54% in 2025, but the outlook is positive 12.39% per year for the next five years.
Tempest Therapeutics Inc (NASDAQ:TPST)’s Major holders
Upon looking at major shareholders, it appears that insiders hold 0.24% of Tempest Therapeutics Inc shares, and 23.02% of them are in the hands of institutional investors. The stock currently has a share float of 23.07%. Tempest Therapeutics Inc stock is held by 30.0 institutions, with BLACKROCK INC. being the largest institutional investor. By 2024-06-30, it held 2.4747% of the shares, which is about 0.55 million shares worth $1.21 million.
FMR LLC, with 1.9426% or 0.43 million shares worth $0.95 million as of 2024-06-30, holds the second largest percentage of outstanding shares.
Vanguard Extended Market Index Fund and Fidelity Extended Market Index Fund were the top two Mutual Funds as of Sep 30, 2024. The former held 174.01 shares worth $0.16 million, making up 0.40% of all outstanding shares. On the other hand, Fidelity Extended Market Index Fund held roughly 121.36 shares worth around $0.11 million, which represents about 0.28% of the total shares outstanding.
